RA PHARMACEUTICALS, INC. Shareholders' Equity
RA PHARMACEUTICALS, INC. had Shareholders' Equity of $262.11 million as of 2019-12-31, per its 10-K filed 2020-02-27.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2020-02-27
- 2019-12-31: Stockholders' Equity Attributable to Parent $262.11M.
- 2019-09-30: Stockholders' Equity Attributable to Parent $293.76M.
- 2019-06-30: Stockholders' Equity Attributable to Parent $173.69M.
- 2019-03-31: Stockholders' Equity Attributable to Parent $191.25M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2019-12-31 | $262.11M 10-K · filed 2020-02-27 | |
| 2019-09-30 | $293.76M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $173.69M 10-Q · filed 2019-11-07 | |
| 2019-03-31 | $191.25M 10-Q · filed 2019-11-07 | |
| 2018-12-31 | $207.12M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $80.46M 10-Q · filed 2019-11-07 | $80.46M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $94.92M 10-Q · filed 2019-11-07 | |
| 2018-03-31 | $108.67M 10-Q · filed 2019-11-07 | |
| 2017-12-31 | $69.18M 10-K · filed 2020-02-27 | |
| 2017-09-30 | $82.58M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $96.18M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $106.92M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $117.22M 10-K · filed 2019-03-07 | |
| 2016-09-30 | -$54.55M 10-Q · filed 2016-11-29 | |
| 2015-12-31 | -$37.20M 10-K · filed 2018-03-14 | |
| 2014-12-31 | -$25.71M 10-K · filed 2018-03-14 | |
| 2013-12-31 | -$20.36M 10-K · filed 2017-03-06 |